Nikola Kenjić, Ph.D.
About Nikola Kenjić, Ph.D.
Nikola Kenjić, Ph.D., is a biochemist and scientist currently working at Terray Therapeutics in Pasadena, California. With a strong background in enzymology and structural biology, he focuses on problem-solving to enhance people's lives through scientific research.
Work at Terray Therapeutics
Nikola Kenjić, Ph.D., has been employed at Terray Therapeutics as a Scientist in Biochemistry since 2021. In this role, he focuses on problem-solving to enhance people's lives through scientific research. His work contributes to the company's drug discovery initiatives, leveraging his expertise in enzymology and structural biology.
Education and Expertise
Nikola Kenjić earned a Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology from The University of Kansas, completing his studies from 2014 to 2019. He also holds a Master of Science (MS) in Biochemistry with a minor in Organic Chemistry from the University of Arizona, obtained in 2013. His academic background is complemented by a Bachelor of Science (BS) in Chemistry from the University of Florida, completed in 2009. His expertise includes enzymology and structural biology, which are critical in drug discovery.
Background
Before joining Terray Therapeutics, Nikola Kenjić held several academic positions. He worked as a Graduate Teaching and Research Assistant at The University of Kansas from 2014 to 2019. Prior to that, he served as a Graduate Teaching Assistant at the University of Arizona from 2012 to 2014. He also completed a postdoctoral research position at the University of California, Riverside, from 2019 to 2021. Additionally, he taught Chemistry at United World College Mostar for seven months in 2011.
Achievements
Nikola Kenjić has contributed to various research efforts throughout his academic and professional career. His focus on using scientific knowledge for social responsibility and leadership reflects his commitment to applying biochemistry in ways that benefit society. His work in enzymology and structural biology has been integral to advancing drug discovery processes.